Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Deng C et al. – The results suggest that aripiprazole has selective effects on the mesolimbic dopaminergic pathway. Selectively reducing dopamine synthesis in VTA is a possible therapeutic mechanism for the long–term efficacy of aripiprazole in controlling schizophrenia symptoms with reduced extrapyramidal side–effects.

Today in Adverse Drug Reactions...keeping you current

Antiretroviral Medications: Adverse Effects on the Kidney
Advances In Chronic Kidney Disease , 12/17/09

Bilateral Acute Angle-closure Glaucoma in a Migraine Patient Receiving Topiramate: A Case Report
The Journal of Emergency Medicine, 12/17/09

Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression
Anesthesiology, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address